Lung TB: Higher dose of rifampicin safe, can boost recurrence-free survival, says ICMR study
New Delhi, July 17 (IANS) A higher dose of rifampicin -- a bactericidal antibiotic used primarily to treat tuberculosis (TB) -- may be safe, and its use can potentially lead to recurrence-free survival in patients with pulmonary TB, according to a recent study by the Indian Council of Medical Research (ICMR).